Neil K Warma's Net Worth
$38.8 Thousand
Who is Neil K Warma?
Neil K Warma does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Opexa Therapeutics, Inc., and ProMIS Neurosciences Inc..
SEC CIK
Neil K Warma's CIK is 0001437911
Past Insider Trading and Trends
2013 was Neil K Warma's most active year for acquiring shares with 9 total transactions. Neil K Warma's most active month to acquire stocks was the month of March. 2010 was Neil K Warma's most active year for disposing of shares, totalling 1 transactions. Neil K Warma's most active month to dispose stocks was the month of March. 2013 saw Neil K Warma paying a total of $16,319.90 for 358,427 shares, this is the most they've acquired in one year. In 2015 Neil K Warma cashed out on 37,247 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Opexa Therapeutics, Inc. (ACER) Snapshot price: $0.6601
President, CEO and Acting CFONeil K Warma owns 144,881 units of Common Stock which is worth $95,635.95. From 2008 to 2016 Neil K Warma acquired a total of 197,628 shares in Opexa Therapeutics, Inc. at a cost of $56,844.16.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
| +34.61% | 37.25K |
—
|
—
| 144.88K |
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| +10.24% | 10K |
$1.11 | $11,100.00 | 107.63K |
Sep 16
| |||
Form 4
| +112.78% | 51.75K |
—
|
—
| 97.63K |
Feb 28
| |||
Form 4
| +165.01% | 28.57K |
—
|
—
| 45.89K |
Nov 8
| |||
Form 4
| +87.41% | 8.08K |
$1.91 | $15,425.16 | 17.32K |
Sep 24
| |||
Form 4
| +6.71% | 581 |
$1.54 | $894.74 | 9.24K |
Jun 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +330.00% | 28.57K |
—
|
—
| 37.23K |
Feb 4 - Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +7.45% | 600 |
$1.33 | $798.00 | 8.66K |
Sep 12 - Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +33.01% | 8K |
$1.63 | $13,020.00 | 32.23K |
Jun 11 - Jun 14
| |||
Form 4
| +702.18% | 21.21K |
$0.50 | $10,606.50 | 24.23K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
∞
| 3.02K |
$1.66 | $4,999.76 | 3.02K |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ProMIS Neurosciences Inc. (PMN) Snapshot price: $2.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |